Doyle JS - Search Results

1

Epidemiology of acute infections in people who inject drugs in Australia.

Attwood LO, O'Keefe D, Higgs P, Vujovic O, Doyle JS, Stewardson AJ. Attwood LO, et al. Among authors: doyle js. Drug Alcohol Rev. 2024 Jan;43(1):304-314. doi: 10.1111/dar.13772. Epub 2023 Nov 23. Drug Alcohol Rev. 2024. PMID: 37995135 Free PMC article. Review.

2

Global policy and access to new hepatitis C therapies for people who inject drugs.

Doyle JS, Aspinall EJ, Hutchinson SJ, Quinn B, Gore C, Wiktor SZ, Hellard ME. Doyle JS, et al. Int J Drug Policy. 2015 Nov;26(11):1064-71. doi: 10.1016/j.drugpo.2015.05.008. Epub 2015 Jun 2. Int J Drug Policy. 2015. PMID: 26118794 Review.

3

Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia.

Scott N, Iser DM, Thompson AJ, Doyle JS, Hellard ME. Scott N, et al. Among authors: doyle js. J Gastroenterol Hepatol. 2016 Apr;31(4):872-82. doi: 10.1111/jgh.13223. J Gastroenterol Hepatol. 2016. PMID: 26514998

4

Injecting drug use in low and middle-income countries: Opportunities to improve care and prevent harm.

O'Keefe D, Stoové M, Doyle J, Dietze P, Hellard M. O'Keefe D, et al. J Viral Hepat. 2017 Sep;24(9):714-724. doi: 10.1111/jvh.12741. Epub 2017 Aug 1. J Viral Hepat. 2017. PMID: 28632952 Review.

5

New hepatitis C antiviral treatments eliminate the virus.

Doyle JS, Thompson AJ, Higgs P, Stoove M, Dietze PM, Hellard ME. Doyle JS, et al. Lancet. 2017 Jul 22;390(10092):358-359. doi: 10.1016/S0140-6736(17)31817-2. Epub 2017 Jul 7. Lancet. 2017. PMID: 28689663 No abstract available.

6

Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study.

Goutzamanis S, Doyle JS, Thompson A, Dietze P, Hellard M, Higgs P; TAP study group. Goutzamanis S, et al. Among authors: doyle js. BMC Infect Dis. 2018 Apr 2;18(1):151. doi: 10.1186/s12879-018-3057-1. BMC Infect Dis. 2018. PMID: 29609552 Free PMC article.

7

Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs.

Latham NH, Pedrana A, Doyle JS, Howell J, Williams B, Higgs P, Thompson AJ, Hellard ME. Latham NH, et al. Among authors: doyle js. J Viral Hepat. 2019 Jul;26(7):919-922. doi: 10.1111/jvh.13087. Epub 2019 Apr 1. J Viral Hepat. 2019. PMID: 30801881

8

Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs.

Wade AJ, Doyle JS, Gane E, Stedman C, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Thompson AJ, Hellard ME. Wade AJ, et al. Among authors: doyle js. Clin Infect Dis. 2020 Apr 15;70(9):1900-1906. doi: 10.1093/cid/ciz546. Clin Infect Dis. 2020. PMID: 31233117 Clinical Trial.

9

Peer to peer communication about hepatitis C treatment amongst people who inject drugs: A longitudinal qualitative study.

Goutzamanis S, Doyle JS, Horyniak D, Higgs P, Hellard M; TAP study group. Goutzamanis S, et al. Among authors: doyle js. Int J Drug Policy. 2021 Jan;87:102983. doi: 10.1016/j.drugpo.2020.102983. Epub 2020 Oct 22. Int J Drug Policy. 2021. PMID: 33126166

10

Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs.

Goutzamanis S, Spelman T, Harney B, Dietze P, Stoove M, Higgs P, Thompson A, Doyle JS, Hellard M. Goutzamanis S, et al. Among authors: doyle js. J Viral Hepat. 2021 Jul;28(7):1068-1077. doi: 10.1111/jvh.13516. Epub 2021 May 3. J Viral Hepat. 2021. PMID: 33880820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page